Source comparison
BPC-157 for Powerlifters: Full Comparison
BPC-157 peptide VEGF upregulation, collagen synthesis, angiogenesis 4–8 weeks for subjective improvement $80–$150 depending on source Animal studies only; no human RCTs Most promising for chronic tendon injuries unresponsive to standard rehab. Worth considerin
This comparison does not assign a generated winner or score.
- BPC-157 peptide
- VEGF upregulation, collagen synthesis, angiogenesis
- 4–8 weeks for subjective improvement
- $80–$150 depending on source
- Animal studies only; no human RCTs
- Most promising for chronic tendon injuries unresponsive to standard rehab. Worth considering after 12+ weeks of failed conservative treatment
- NSAIDs (ibuprofen, naproxen)
- COX enzyme inhibition, inflammation reduction
- Immediate pain relief, no tissue repair acceleration
- $10–$30 OTC
- Extensive human data; proven symptom management
- Useful for acute pain control but may impair long-term tendon healing. Avoid chronic use during rehab phases
- Collagen supplementation
- Provides substrate for collagen synthesis
- 8–12 weeks for measurable tendon adaptation
- $30–$60 for hydrolyzed collagen
- Human trials show modest improvements in tendon stiffness and pain
- Proven benefit when combined with loading exercises; cost-effective first-line adjunct before considering peptides
- Physical therapy + eccentric loading
- Mechanical stimulus triggers collagen remodeling
- 12–16 weeks standard rehab timeline
- $500–$1500 depending on insurance
- Gold standard evidence; most tendon injuries resolve with structured PT
- Non-negotiable foundation. Peptides are adjuncts, not replacements, for proper rehab programming
- Platelet-rich plasma (PRP) injection
- Growth factor delivery to injury site
- 6–12 weeks; single injection or series
- $500–$1500 per injection
- Mixed evidence; some tendon types respond better than others
- More invasive and expensive than peptides; consider if BPC-157 protocol + rehab fails after 16+ weeks
- BPC-157 occupies a middle ground: more mechanistically targeted than oral supplements, less invasive than PRP injections, but without the clinical validation NSAIDs and structured rehab possess. Use it strategically, not universally.